China Case Control Avian Influenza
NCT00428753 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2008-05-30
Summary
This study will determine risk factors of human infection with avian influenza A virus, also known as bird flu virus. Certain risk factors such as exposure to poultry, travel history, health status, and other factors may affect one's risk of getting bird flu. Study participants will include individuals, older than age 1, that tested positive for influenza A (H5N1) in a previous surveillance program and controls (individuals that have not tested positive for avian influenza A (H5N1) and have no fever or respiratory symptoms). There will be 1 study visit during which volunteers will be asked detailed questions about their health, work, and travel habits. Study participants will be asked to donate a blood sample to test for antibodies, the part of the blood that fights infection.
Conditions
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-01-31
- Completion
- 2008-01-31
Countries
- China
Study Locations
More Related Trials
-
Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
NCT01658800 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults
NCT00347672 ·Status: COMPLETED ·Phase: PHASE1
-
Vaccine for Prevention of Bird Flu
NCT00776711 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)
NCT00110279 ·Status: COMPLETED ·Phase: PHASE1
-
Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults
NCT00488046 ·Status: COMPLETED ·Phase: PHASE1
-
Studies of Avian Influenza Transmission to Humans in Egypt
NCT01150552 ·Status: COMPLETED
-
Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine
NCT00311727 ·Status: COMPLETED ·Phase: NA
-
Safety Study of an Oral Vaccine to Prevent Avian Influenza
NCT01335347 ·Status: COMPLETED ·Phase: PHASE1
-
Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses
NCT00417560 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure
NCT01045564 ·Status: WITHDRAWN ·Phase: PHASE2
-
Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy Adults
NCT00853255 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen mRNA-LNP in Healthy Adults
NCT07019883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
NCT02839330 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I Clinical Trial With Whole Virus Inactivated Influenza H5N1 Vaccine in Healthy Adolescents and Adults
NCT01676675 ·Status: WITHDRAWN ·Phase: PHASE1
-
Immunogenicity Study of S-OIV H1N1 Influenza Vaccine
NCT01096225 ·Status: UNKNOWN
-
Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally
NCT00489931 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Of A Recombinant H5N1 Vaccine In Adults
NCT01250795 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1
NCT01006798 ·Status: COMPLETED ·Phase: PHASE1
-
Inactivated Influenza A/H5N1 Vaccine in the Elderly
NCT00230750 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults
NCT00516035 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years
NCT01560793 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)
NCT00380237 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1)
NCT01024673 ·Status: COMPLETED
-
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month
NCT01040078 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluating the Safety and Immunogenicity of a H7N9 Vaccine for the Prevention of Influenza H7N9 Disease in Adults 50 to 70 Years Old
NCT02274545 ·Status: COMPLETED ·Phase: PHASE1